CardiAQ's mitral valve performs well in preclinical study

10/1/2009 | Clinica (subscription required)

CardiAQ Valve Technologies' transcatheter mitral valve implantation tool enabled doctors to accurately place the implantable valve relative to the mitral valve annulus as well as securely anchor the implantable device to the mitral anatomy without depending on radial force, according to preclinical trials. The TMVI system treats mitral valve regurgitation by implanting a mitral valve inside a beating heart with the aid of a catheter.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA